UT M. D. ANDERSON CANCER CENTER

Postdoctoral Position in Cancer Therapy and Molecular Signaling  

A postdoctoral position is available immediately to conduct preclinical studies using nanoparticles for cancer therapy and investigate molecular signaling of anticancer agents at the Department of Thoracic and Cardiovascular Surgery, The University of Texas M. D. Anderson Cancer Center. The studies involve formulation and testing of nanoparticles containing tumor suppressor genes, siRNA’s and small molecules for therapy. Additionally, molecular studies involving signal transduction and cellular apoptosis will be investigated.  Highly motivated and interactive colleagues with Ph.D. and/or M.D. who are interested in cancer therapy and molecular signaling are encouraged to apply. Experience in one of the following areas is highly preferred: nanoparticle sysnthesis and formulation, molecular biology, signal transduction, and animal tumor models.  M. D. Anderson Cancer Center is an equal opportunity employer and does not discriminate on the basis of race, color, nation origin, gender, sexual orientation, age, religion, disability or veteran status except where such distinction is required by law. All positions at The University of Texas M. D. Anderson Cancer Center are security sensitive and subject to examination of criminal history record information.  The University of Texas M. D. Anderson Cancer Center is smoke-free and drug-free environment.

Please submit curriculum vitae, statement of research interest and names/address of three references to:

Dr. Rajagopal Ramesh

Department of Thoracic and Cardiovascular Surgery

The University of Texas M. D. Anderson Cancer Center

1515 Holcombe Blvd., Unit 445

Houston, TX 77030

Email: rramesh@mdanderson.org

Phone: 713-563-9144